Form 4 for TMO Thermo Fisher Scientific
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-02 · accession 0001127602-21-026669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-08-06 | TMO | SPERLING SCOTT M | Dir | G - Gift | $0.00 | -4,000 | 71.7K | -5% | $0 |
| D | 2021-10-05 | 2021-10-02 | TMO | SPERLING SCOTT M | Dir | A - Grant | $0.00 | +64.40 | 16.2K | +0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-06 | G | D | 4,000 | $0.00 | 71,701 | D | — | — | |
| 2 | Derivative | Phantom Stock Units | 2021-10-02 | A | A | 64.40 | $0.00 | 16,207.98 | D | — · — to — | 64.40 Common Stock | (F1) Convertible into Common Stock on a 1-for-1 basis. (F2) Represents stock units credited to the Reporting Person's account as of October 2, 2021, at a price of $572.72 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. |